Logo image of CTXS

Citrix Systems Inc (CTXS) Stock Fundamental Analysis

NASDAQ:CTXS - Nasdaq - US1773761002 - Common Stock - Currency: USD

103.9  +0.04 (+0.04%)

After market: 103.93 +0.03 (+0.03%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to CTXS. CTXS was compared to 283 industry peers in the Software industry. CTXS may be in some trouble as it scores bad on both profitability and health. CTXS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

CTXS had positive earnings in the past year.
CTXS Yearly Net Income VS EBIT VS OCF VS FCFCTXS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 200M 400M 600M 800M 1B

1.2 Ratios

Industry RankSector Rank
ROA 4.71%
ROE 40.08%
ROIC 9.05%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CTXS Yearly ROA, ROE, ROICCTXS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 100 200 300 400

1.3 Margins

Industry RankSector Rank
OM 14.43%
PM (TTM) 9.97%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CTXS Yearly Profit, Operating, Gross MarginsCTXS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 20 40 60 80

More info and screens

0

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CTXS is destroying value.
The number of shares outstanding for CTXS has been increased compared to 1 year ago.
Compared to 1 year ago, CTXS has a worse debt to assets ratio.
CTXS Yearly Shares OutstandingCTXS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M
CTXS Yearly Total Debt VS Total AssetsCTXS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2B 4B 6B

2.2 Solvency

An Altman-Z score of 2.89 indicates that CTXS is not a great score, but indicates only limited risk for bankruptcy at the moment.
A Debt/Equity ratio of 3.92 is on the high side and indicates that CTXS has dependencies on debt financing.
Industry RankSector Rank
Debt/Equity 3.92
Debt/FCF N/A
Altman-Z 2.89
ROIC/WACC0.8
WACC11.34%
CTXS Yearly LT Debt VS Equity VS FCFCTXS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 1B 2B 3B

2.3 Liquidity

CTXS has a Current Ratio of 0.82. This is a bad value and indicates that CTXS is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.81 indicates that CTXS may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.82
Quick Ratio 0.81
CTXS Yearly Current Assets VS Current LiabilitesCTXS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 1B 2B 3B

More info and screens

4

3. Growth

3.1 Past

CTXS shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.00%.
The Earnings Per Share has been growing slightly by 0.08% on average over the past years.
CTXS shows a small growth in Revenue. In the last year, the Revenue has grown by 4.72%.
The Revenue has been growing slightly by 3.29% on average over the past years.
EPS 1Y (TTM)4%
EPS 3Y-1.87%
EPS 5Y0.08%
EPS Q2Q%28.23%
Revenue 1Y (TTM)4.72%
Revenue growth 3Y2.66%
Revenue growth 5Y3.29%
Sales Q2Q%5.84%

3.2 Future

Based on estimates for the next years, CTXS will show a small growth in Earnings Per Share. The EPS will grow by 4.00% on average per year.
The Revenue is expected to grow by 2.91% on average over the next years.
EPS Next Y7.65%
EPS Next 2Y5.63%
EPS Next 3Y4.95%
EPS Next 5Y4%
Revenue Next Year4.15%
Revenue Next 2Y2.56%
Revenue Next 3Y3.45%
Revenue Next 5Y2.91%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CTXS Yearly Revenue VS EstimatesCTXS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B
CTXS Yearly EPS VS EstimatesCTXS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 18.16, the valuation of CTXS can be described as rather expensive.
Compared to an average S&P500 Price/Earnings ratio of 29.62, CTXS is valued a bit cheaper.
With a Price/Forward Earnings ratio of 17.47, CTXS is valued on the expensive side.
When comparing the Price/Forward Earnings ratio of CTXS to the average of the S&P500 Index (22.70), we can say CTXS is valued slightly cheaper.
Industry RankSector Rank
PE 18.16
Fwd PE 17.47
CTXS Price Earnings VS Forward Price EarningsCTXS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 19.86
CTXS Per share dataCTXS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CTXS does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)2.38
PEG (5Y)241.49
EPS Next 2Y5.63%
EPS Next 3Y4.95%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CTXS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Citrix Systems Inc

NASDAQ:CTXS (9/29/2022, 8:17:34 PM)

After market: 103.93 +0.03 (+0.03%)

103.9

+0.04 (+0.04%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)07-26 2022-07-26/amc
Earnings (Next)11-03 2022-11-03/bmo
Inst Owners0%
Inst Owner Change0%
Ins Owners7.14%
Ins Owner Change0%
Market Cap13.18B
Analysts77.78
Price Target106.08 (2.1%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend1.48
Dividend Growth(5Y)61.71%
DP27.94%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 18.16
Fwd PE 17.47
P/S 3.98
P/FCF N/A
P/OCF N/A
P/B 15.99
P/tB N/A
EV/EBITDA 19.86
EPS(TTM)5.72
EY5.51%
EPS(NY)5.95
Fwd EY5.72%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS26.12
BVpS6.5
TBVpSN/A
PEG (NY)2.38
PEG (5Y)241.49
Profitability
Industry RankSector Rank
ROA 4.71%
ROE 40.08%
ROCE N/A
ROIC 9.05%
ROICexc N/A
ROICexgc 61.4%
OM 14.43%
PM (TTM) 9.97%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 3.92
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.82
Quick Ratio 0.81
Altman-Z 2.89
F-Score6
WACC11.34%
ROIC/WACC0.8
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4%
EPS 3Y-1.87%
EPS 5Y0.08%
EPS Q2Q%28.23%
EPS Next Y7.65%
EPS Next 2Y5.63%
EPS Next 3Y4.95%
EPS Next 5Y4%
Revenue 1Y (TTM)4.72%
Revenue growth 3Y2.66%
Revenue growth 5Y3.29%
Sales Q2Q%5.84%
Revenue Next Year4.15%
Revenue Next 2Y2.56%
Revenue Next 3Y3.45%
Revenue Next 5Y2.91%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A